INVOX
LIVE

Serial Number

79347617

Owner

invoX Pharma Limited

Attorney

Catherine J. Holland

Filing Date

May 26, 2022

Add to watchlist:

No watchlists yet
View on USPTO

INVOX Trademark

Serial Number: 79347617 • Registration: 7333791

INVOX is a trademark filed by invoX Pharma Limited on May 26, 2022. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 36 (Insurance & Financial), Class 42 (Computer & Scientific), Class 45 (Legal & Security Services). The application is currently registered and active.

Owner Contact Info

invoX Pharma Limited (4 trademarks)

1 Princeton Mews,

Entity Type: 99

Trademark Details

Filing Date

May 26, 2022

Registration Date

March 26, 2024

Published for Opposition

January 9, 2024

Goods & Services

Financing and equity investment services in the fields of pharmaceuticals, biotechnology life sciences; capital financing services in the fields of pharmaceuticals, biotechnology, life sciences; making direct and indirect investments, namely providing venture capital, private equity and investment funding for the development and commercialization of products and management of product portfolios in the fields of pharmaceuticals, biotechnology, life sciences; investment services, namely, asset and investment acquisition, and development services; none of the aforesaid services being in relation to the examination, processing, transportation or testing services relating to veterinary or medical samples; none of the aforesaid services being in relation to diagnostic applications by means of medical samples or in the field of laboratory automation for diagnostic purposes by means of medical samples, specimen handling or sample preparation or being in the field of software and IT services for enabling and/or supporting medical, patient and veterinary sample data testing, processing and/or analysis

Licensing of intellectual property rights; licensing of intellectual property in the field of pharmaceutical, biotechnology, life sciences; none of the aforesaid being in relation to the examination, processing, transportation or testing services relating to veterinary or medical samples; none of the aforesaid services being in relation to diagnostic applications by means of medical samples or in the field of laboratory automation for diagnostic purposes by means of medical samples, specimen handling or sample preparation or being in the field of software and IT services for enabling and/or supporting medical, patient and veterinary sample data testing, processing and/or analysis

Surgical instruments and apparatus, and medical devices, namely, inhalation devices in the field of drug delivery systems, excluding medical and veterinary sample containers, processing and analysis machines and test kits and personal protective equipment (PPE); inhalers for medical and pharmaceutical purposes; none of the aforesaid being goods for use in the examination, processing, transportation or testing of veterinary or medical samples or for use in diagnostics or in laboratory automation for diagnostic purposes, sample handling or sample preparation enabling and/or supporting medical, patient and veterinary data testing, processing and/or analysis

Pharmaceutical research and development in the field of biotechnology, medical devices in the field of drug delivery systems; scientific research for clinical, medical and pharmaceutical purposes in the field of biotechnology, medical devices for drug delivery systems and life sciences; scientific research and development in the field of biotechnology medical devices, life sciences and healthcare technology; pharmaceutical products development and medical device product development in the field of biotechnology, medical devices for drug delivery systems and life sciences; none of the aforesaid being in relation to the examination, processing, transportation or testing services relating to veterinary; none of the aforesaid services being in relation to diagnostic applications by means of medical samples or in the field of laboratory automation for diagnostic purposes by means of medical samples, specimen handling or sample preparation or being in the field of software and IT services for enabling and/or supporting medical, patient and veterinary sample data testing, processing and/or analysis

Pharmaceuticals for use in oncology, cardio-respiratory, haematology and immunity, paediatric and regenerative medicine; Pharmaceutical preparations and substances for oncology, cardio-respiratory, haematology and immunity, paediatric and regenerative medicine and for the prevention and treatment of inflammation and infectious diseases; chemical preparations for pharmaceutical purposes, namely, for use in oncology, cardio-respiratory, haematology and immunity, paediatric and regenerative medicine and for the treatment of inflammation and infectious diseases; chemical reagents for medical use; biotechnological preparations for medical use for use in oncology, cardio-respiratory, haematology and immunity, paediatric and regenerative medicine and for the treatment of inflammation and infectious diseases; biological adjuvants for medical purposes; biochemical preparations for medical use for use in oncology, cardio-respiratory, haematology and immunity, paediatric and regenerative medicine and for the treatment of inflammation and infectious diseases; preparations for deodorizing air; medicated deodorants for health and medical purposes; oils for medical purposes; air purifying preparations, pharmaceutical preparations for inhalers; none of the aforesaid goods being disinfectants or sanitary preparations, and not being adapted for use as disinfectant or sanitisers; none of the aforesaid being goods for use in diagnostics or for use in the examination, processing, transportation or testing of veterinary or medical samples

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Apr 23, 2026 NREP
LIMITATION OF GOODS RECEIVED FROM IB
May 30, 2025 LIMG
FINAL DECISION TRANSACTION PROCESSED BY IB
Nov 23, 2024 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Nov 5, 2024 FICS
FINAL DISPOSITION PROCESSED
Oct 7, 2024 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jun 27, 2024 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Mar 26, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Mar 26, 2024 R.PR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Feb 13, 2024 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jan 24, 2024 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Jan 24, 2024 OPNR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 9, 2024 NPUB
PUBLISHED FOR OPPOSITION
Jan 9, 2024 PUBO
NOTIFICATION PROCESSED BY IB
Jan 8, 2024 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Dec 20, 2023 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Dec 20, 2023 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 20, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 5, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 7, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 6, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 6, 2023 TROA
LIMITATION FROM THE IB - REQUEST EXAM REVIEW
Oct 24, 2023 LIME
LIMITATION OF GOODS RECEIVED FROM IB
Jul 30, 2023 LIMG
REFUSAL PROCESSED BY IB
May 24, 2023 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
May 4, 2023 RFCS
REFUSAL PROCESSED BY MPU
May 4, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 16, 2023 RFCR
NON-FINAL ACTION WRITTEN
Mar 15, 2023 CNRT
ASSIGNED TO EXAMINER
Mar 14, 2023 DOCK
APPLICATION FILING RECEIPT MAILED
Aug 23, 2022 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 19, 2022 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Aug 18, 2022 REPR